1. Expression of human β-defensin-2 in the prostate.
- Author
-
Hae Jong Kim, Ja Rang Jung, Hea Jin Kim, Shin Young Lee, In Ho Chang, Tae Jin Lee, Wonyong Kim, and Soon Chul Myung
- Subjects
CELL lines ,PROSTATE cancer ,CANCER cells ,POLYMERASE chain reaction ,ENZYME-linked immunosorbent assay ,ENDOTOXINS - Abstract
OBJECTIVE To investigate the expression and regulation of human β-defensin-2 (HBD-2) in the prostate. PATIENTS AND METHODS Normal human prostate epithelial cell line (RWPE-1), human prostate cancer cell lines (DU-145, PC-3), and paraffin-embedded prostate tissue from patients with benign prostatic hyperplasia (BPH) were analysed by RT-PCR and immunohistochemical staining. HBD-2 expression was also analysed by RT-PCR and ELISA in RWPE-1 cells treated with lipopolysaccharide (LPS). Nuclear factor-κB (NF-κB) activation was assessed by IκBα immunoblotting and electrophoretic mobility shift assay (EMSA). RESULTS BPH tissue and all of the tested prostate cell lines other than PC-3 constitutively express HBD-2 mRNA. HBD-2 protein was strongly detected in prostate gland tissue surrounded by inflammatory cells including macrophages. Exposure to LPS induced HBD-2 upregulation and NF-κB activation, as assessed by IκBα phosphorylation and degradation in RWPE-1 cells. Bay11-7082, an NF-κB inhibitor prevented LPS-induced HBD-2 production in RWPE-1 cells. CONCLUSIONS Prostate epithelial cells may constitutively express HBD-2, and its expression was upregulated by LPS. Our data indicate that HBD-2 may be an important immunomodulatory factor in prostate function. Expression of HBD-2 in normal prostates and the potential role of HBD-2 in prostatitis and BPH should be addressed in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF